Renee Mason, MD
Obstetrics & Gynecology · Maumee, OHNPI 1063404267
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,294 of the $38,212 with a category attached, or 87.1%. Organon accounts for 73.8% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2023 at $11,413 and has fallen 83.6% since, to $1,870 in 2025. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $194.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$28K
- Merck$6K
- Intuitive Surgical$2K
- AbbVie$394
- Novo Nordisk$207
- Smith+Nephew$151
- plus $1K from 28 others
What the payments were for
- Speaking & faculty fees$33,29487%
- Travel & lodging$1,0233%
- Food & beverage$2,3836%
- Education$1,5124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 53 | $28,192 |
| Merck | 17 | $5,655 |
| Intuitive Surgical | 14 | $2,343 |
| AbbVie(2 entities) | 29 | $394 |
| Novo Nordisk | 7 | $207 |
| Smith+Nephew | 2 | $151 |
| Astellas Pharma US Inc | 9 | $149 |
| Mayne Pharma Commercial LLC | 7 | $148 |
| Bayer | 8 | $141 |
| Sumitomo Pharma America, Inc. | 5 | $102 |
| Sage Therapeutics, LLC | 3 | $81 |
| Pfizer | 5 | $74 |
| Shield Therapeutics Inc | 4 | $66 |
| Therapeuticsmd, Inc. | 4 | $66 |
| Amgen | 4 | $58 |
| Exeltis, USA Inc. | 3 | $52 |
| Hologic Sales And Service, LLC | 4 | $45 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Myovant Sciences Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Biogen | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $17 |
| Avanos Medical | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Optumhealth Care Solutions, LLC | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
| Lupin Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$31,646
- DAVINCI XI$1,500
- Da Vinci Surgical System$773
- PICO$136
- Saxenda$120
How this compares
$38,212 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 31 | $1,230 |
| Estradiol (Once Weekly)Estradiol | 12 | $497 |
| Clobetasol Propionate | 16 | $485 |
| ValacyclovirValacyclovir Hcl | 14 | $269 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Maumee
- Anne RuchMaumee$16K
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.